Last 12 months
Inside the activity.
4 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 3 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2017 Filed Mar 3, 2017 21:23 UTC |
Haytaian Peter DEVP & President, GBD
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 19,908 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001127602-17-010153 · form4.xml · derivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,908 Underlying: Common Stock · 19,908 shares Expires 2027-03-01 F3 · derivative.exercise_date: The option represents a right to purchase a total of 19,908 shares, and is exercisable in six semi-annual installments of 3,318 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:23 UTC |
Haytaian Peter DEVP & President, GBD
|
GrantCommon Stock | 4,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-010153 · form4.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,926 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,622 shares each on 3/1/2018 and 3/1/2019, and 1,623 on 3/1/2020. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:23 UTC |
Haytaian Peter DEVP & President, GBD
|
Tax withholdingCommon Stock | 706 | $166.97 | $117,880.82 |
DisclosureSEC source: 0001127602-17-010153 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,059 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:22 UTC |
Tomas Jose D.EVP & Chief HR Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 13,782 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001127602-17-010149 · form4.xml · derivative · entry 4 Tomas Jose D. · CIK 0001552292 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,782 Underlying: Common Stock · 13,782 shares Expires 2027-03-01 F3 · derivative.exercise_date: The option represents a right to purchase a total of 13,782 shares, and is exercisable in six semi-annual installments of 2,297 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:22 UTC |
Tomas Jose D.EVP & Chief HR Officer
|
GrantCommon Stock | 3,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-010149 · form4.xml · nonDerivative · entry 2 Tomas Jose D. · CIK 0001552292 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,890.9862 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,123 shares each on 3/1/2018, 3/1/2019 and 3/1/2020. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:22 UTC |
Tomas Jose D.EVP & Chief HR Officer
|
Tax withholdingCommon Stock | 391 | $166.97 | $65,285.27 |
DisclosureSEC source: 0001127602-17-010149 · form4.xml · nonDerivative · entry 1 Tomas Jose D. · CIK 0001552292 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,521.9862 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:18 UTC |
Samitt Craig EEVP & Chief Clinical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 13,782 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001127602-17-010145 · form4.xml · derivative · entry 3 Samitt Craig E · CIK 0001601851 · EVP & Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,782 Underlying: Common Stock · 13,782 shares Expires 2027-03-01 F3 · derivative.exercise_date: The option represents a right to purchase a total of 13,782 shares, and is exercisable in six semi-annual installments of 2,297 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:18 UTC |
Samitt Craig EEVP & Chief Clinical Officer
|
GrantCommon Stock | 3,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-010145 · form4.xml · nonDerivative · entry 2 Samitt Craig E · CIK 0001601851 · EVP & Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,369 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,123 shares each on 3/1/2018, 3/1/2019 and 3/1/2020. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:18 UTC |
Samitt Craig EEVP & Chief Clinical Officer
|
Tax withholdingCommon Stock | 408 | $166.97 | $68,123.76 |
DisclosureSEC source: 0001127602-17-010145 · form4.xml · nonDerivative · entry 1 Samitt Craig E · CIK 0001601851 · EVP & Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:18 UTC |
Gallina John EEVP & Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 19,908 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001127602-17-010143 · form4.xml · derivative · entry 4 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,908 Underlying: Common Stock · 19,908 shares Expires 2027-03-01 F3 · derivative.exercise_date: The option represents a right to purchase a total of 19,908 shares, and is exercisable in six semi-annual installments of 3,318 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:18 UTC |
Gallina John EEVP & Chief Financial Officer
|
GrantCommon Stock | 4,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-010143 · form4.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,830 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,622 shares each on 3/1/2018 and 3/1/2019, and 1,623 on 3/1/2020. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:18 UTC |
Gallina John EEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 165 | $166.97 | $27,550.05 |
DisclosureSEC source: 0001127602-17-010143 · form4.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,963 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:17 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 810 | $0.00 Strike: $131.80 | $0.00 |
DisclosureSEC source: 0001127602-17-010136 · form4.xml · derivative · entry 10 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,622 Underlying: Common Stock · 810 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option represents a right to purchase a total of 2,432 shares, became exercisable in six semi-annual installments, with four installments of 405 shares each and two installments of 406 shares each, beginning on September 1, 2016, which was the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:17 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,141 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001127602-17-010136 · form4.xml · derivative · entry 9 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,141 Underlying: Common Stock · 2,141 shares Expires 2027-03-01 F3 · derivative.exercise_date: The option represents a right to purchase a total of 2,141 shares, and is exercisable in six semi-annual installments, with one installment of 356 shares and five installments of 357 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:17 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
SaleCommon Stock | 810 | $166.44 | $134,816.40 |
DisclosureSEC source: 0001127602-17-010136 · form4.xml · nonDerivative · entry 4 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,773 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:17 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 810 | $131.80 | $106,758.00 |
DisclosureSEC source: 0001127602-17-010136 · form4.xml · nonDerivative · entry 3 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:17 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
GrantCommon Stock | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-010136 · form4.xml · nonDerivative · entry 2 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,773 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 175 shares each on 3/1/2018, 3/1/2019 and 3/1/2020. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:17 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 72 | $166.97 | $12,021.84 |
DisclosureSEC source: 0001127602-17-010136 · form4.xml · nonDerivative · entry 1 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,248 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:15 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,314 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001127602-17-010132 · form4.xml · derivative · entry 4 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,314 Underlying: Common Stock · 15,314 shares Expires 2027-03-01 F3 · derivative.exercise_date: The option represents a right to purchase a total of 15,314 shares, and is exercisable in six semi-annual installments, with four installments of 2,552 shares each and two installments of 2,553 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:15 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
GrantCommon Stock | 3,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-010132 · form4.xml · nonDerivative · entry 2 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,902.1293 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,248 shares each on 3/1/2018, 3/1/2019 and 3/1/2020. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:15 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
Tax withholdingCommon Stock | 591 | $166.97 | $98,679.27 |
DisclosureSEC source: 0001127602-17-010132 · form4.xml · nonDerivative · entry 1 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,158.1293 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| January 09, 2017 Filed Jan 10, 2017 21:05 UTC |
Tomas Jose D.EVP & Chief HR Officer
|
SaleCommon Stock | 6,500 | $142.92 | $928,980.00 |
DisclosureSEC source: 0001127602-17-001432 · form4.xml · nonDerivative · entry 1 Tomas Jose D. · CIK 0001552292 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,912.9862 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2016. F2 · price: This transaction was executed in multiple trades at prices ranging from $142.56 to $143.49. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 21:17 UTC |
Haytaian Peter DEVP & President, GBD
|
Tax withholdingCommon Stock | 654 | $144.69 | $94,627.26 |
DisclosureSEC source: 0001127602-16-070124 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,765 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 21:04 UTC |
Swedish JosephDirector · Chair, President & CEO
|
SaleCommon Stock | 1,637 | $145.19 | $237,676.03 |
DisclosureSEC source: 0001127602-16-069898 · form4.xml · nonDerivative · entry 3 Swedish Joseph · CIK 0001179745 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,034 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2016. F4 · price: This transaction was executed in multiple trades at prices ranging from $145.03 to $145.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 21:04 UTC |
Swedish JosephDirector · Chair, President & CEO
|
SaleCommon Stock | 2,930 | $144.30 | $422,799.00 |
DisclosureSEC source: 0001127602-16-069898 · form4.xml · nonDerivative · entry 2 Swedish Joseph · CIK 0001179745 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,671 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2016. F3 · price: This transaction was executed in multiple trades at prices ranging from $144.02 to $145.00. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 21:04 UTC |
Swedish JosephDirector · Chair, President & CEO
|
SaleCommon Stock | 3,609 | $143.44 | $517,674.96 |
DisclosureSEC source: 0001127602-16-069898 · form4.xml · nonDerivative · entry 1 Swedish Joseph · CIK 0001179745 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,601 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2016. F2 · price: This transaction was executed in multiple trades at prices ranging from $143.02 to $143.90. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 02, 2016 Filed Dec 6, 2016 21:05 UTC |
Tomas Jose D.EVP & Chief HR Officer
|
Tax withholdingCommon Stock | 1,043 | $145.10 | $151,339.30 |
DisclosureSEC source: 0001127602-16-069253 · form4.xml · nonDerivative · entry 1 Tomas Jose D. · CIK 0001552292 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,412.9862 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. F2 · balance_after: Includes 203.001 shares acquired under a dividend reinvestment program from June 2014 to September 2015. F3 · balance_after: Includes 92.42 shares acquired under the Anthem, Inc. Employee Stock Purchase Plan, in a transaction exempt under Rule 16b-3. Read SEC document |
| November 22, 2016 Filed Nov 22, 2016 21:16 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
SaleCommon Stock | 820 | $138.29 | $113,397.80 |
DisclosureSEC source: 0001127602-16-068103 · form4.xml · nonDerivative · entry 1 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320 Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 21:08 UTC |
Swedish JosephDirector · Chair, President & CEO
|
SaleCommon Stock | 8,171 | $134.44 | $1,098,509.24 |
DisclosureSEC source: 0001127602-16-066941 · form4.xml · nonDerivative · entry 2 Swedish Joseph · CIK 0001179745 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,210 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2016. F2 · price: This transaction was executed in multiple trades at prices ranging from $133.89 to $134.66. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 21:08 UTC |
Swedish JosephDirector · Chair, President & CEO
|
SaleCommon Stock | 16,342 | $130.00 | $2,124,460.00 |
DisclosureSEC source: 0001127602-16-066941 · form4.xml · nonDerivative · entry 1 Swedish Joseph · CIK 0001179745 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,381 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2016. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:19 UTC |
Samitt Craig EEVP & Chief Clinical Officer
|
Tax withholdingCommon Stock | 276 | $122.90 | $33,920.40 |
DisclosureSEC source: 0001127602-16-064328 · form4.xml · nonDerivative · entry 1 Samitt Craig E · CIK 0001601851 · EVP & Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,408 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:17 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,175 | $0.00 Strike: $122.90 | $0.00 |
DisclosureSEC source: 0001127602-16-064323 · form4.xml · derivative · entry 2 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,175 Underlying: Common Stock · 2,175 shares Expires 2026-10-03 F2 · derivative.exercise_date: The option represents a right to purchase a total of 2,175 shares, and is exercisable in six semi-annual installments, with three installments of 362 shares each and three installments of 363 shares each, beginning on April 3, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:17 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
GrantCommon Stock | 509 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-064323 · form4.xml · nonDerivative · entry 1 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,749.1293 F1 · shares: Represents restricted share units. Restrictions lapse as follows: 169 shares on 10/3/17, and 170 shares each on 10/3/18 and 10/3/19. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.